Since existing studies primarily focus on the pulmonary effects of different CFTR modulators, future directions should encompass an exploration of their short-term and long-term impacts on G-I distress, including their role in preventing G-I cancer, along with considerations of optimal modulator-therapy timing. Here, CFTR is linked to cancer.